Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer

Abstract

Background

The National Death Index (NDI) is a centralized database containing information from death certificates that are frequently referenced by health and medical investigators to ascertain vital statistics. Yet, it commonly includes misclassified causes of death. Since the NDI is frequently relied upon in studies that evaluate outcomes following radical prostatectomy (RP) for prostate cancer (PC), we evaluated its validity by referencing mortality data from the Shared Equal Access Regional Cancer Hospital (SEARCH) database which is a prospectively managed database of 5009 Veterans who underwent a RP at eight Veterans Affairs medical centers between 1982 and 2016.

Methods

We compared vital status, cause of death and date of death from the SEARCH database with the NDI.

Results

A total of 1312 men in SEARCH were deceased, yet the NDI reported 17% (219) of those men as still alive. Among the 1093 men who had concordant vital status in both SEARCH and NDI, the date of death was an exact match within one day, a week, or 31 days in 94%, 97%, 99%, and 100%, respectively. Of those men coded as dying from prostate cancer in the SEARCH database (nā€‰=ā€‰105), 12% were coded as having died from non-PC causes in the NDI. Meanwhile, among patients coded by the NDI as having died of PC (nā€‰=ā€‰139), 34% were coded in SEARCH as having died of non-PC causes.

Conclusions

These findings demonstrate that the NDI provides accurate dates of death, but frequently misclassifies whether a death was due to prostate cancer. Studies that rely upon death certificates, as captured in the NDI, may be unreliable to report prostate cancer-specific mortality rates after prostatectomy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW, Han M. Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology. 2010;76:553ā€“7.

    ArticleĀ  Google ScholarĀ 

  2. Mendhiratta N, Lee T, Prabhu V, Llukani E, Lepor H. 10-Year mortality after radical prostatectomy for localized prostate cancer in the prostate-specific antigen screening era. Urology. 2015;86:783ā€“8.

    ArticleĀ  Google ScholarĀ 

  3. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010;116:5226ā€“34.

    ArticleĀ  Google ScholarĀ 

  4. https://www.cdc.gov/nchs/data/factsheets/factsheet_ndi.htm. Accessed 2019.

  5. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol. 2000;163:519ā€“23.

    ArticleĀ  CASĀ  Google ScholarĀ 

  6. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. Jama. 1997;277:467ā€“71.

    ArticleĀ  CASĀ  Google ScholarĀ 

  7. Satariano WA, Ragland KE, Van Den Eeden SK. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998;83:1180ā€“8.

    ArticleĀ  CASĀ  Google ScholarĀ 

  8. Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R, et al. Surgery versus radiotherapy for clinically-localized prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;70:21ā€“30.

    ArticleĀ  Google ScholarĀ 

  9. Sooriakumaran P, Nyberg T, Akre O, Haendler L, Heus I, Olsson M, et al. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ. 2014;348:g1502.

    ArticleĀ  Google ScholarĀ 

  10. McGivern L, Shulman L, Carney JK, Shapiro S, Bundock E. Death certification errors and the effect on mortality statistics. Public Health Rep. 2017;132:669ā€“75.

    ArticleĀ  Google ScholarĀ 

  11. Johnson CJ, Hahn CG, Fink AK, German RR. Variability in cancer death certificate accuracy by characteristics of death certifiers. Am J Forensic Med Pathol. 2012;33:137ā€“42.

    ArticleĀ  Google ScholarĀ 

  12. German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 2011;35:126ā€“31.

    ArticleĀ  Google ScholarĀ 

  13. Yin D, Morris CR, Bates JH, German RR. Effect of misclassified underlying cause of death on survival estimates of colon and rectal cancer. J Natl Cancer Inst. 2011;103:1130ā€“3.

    ArticleĀ  Google ScholarĀ 

Download references

Acknowledgements

Support for this study was provided by the NIH/NCI under Award Number P50CA09231 and NIH K24 CA160653.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Drew Moghanaki.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisherā€™s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moghanaki, D., Howard, L.E., De Hoedt, A. et al. Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer. Prostate Cancer Prostatic Dis 22, 633ā€“635 (2019). https://doi.org/10.1038/s41391-019-0146-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-019-0146-1

This article is cited by

Search

Quick links